204 related articles for article (PubMed ID: 24189220)
1. Aberrant expression of posterior HOX genes in well differentiated histotypes of thyroid cancers.
Cantile M; Scognamiglio G; La Sala L; La Mantia E; Scaramuzza V; Valentino E; Tatangelo F; Losito S; Pezzullo L; Chiofalo MG; Fulciniti F; Franco R; Botti G
Int J Mol Sci; 2013 Nov; 14(11):21727-40. PubMed ID: 24189220
[TBL] [Abstract][Full Text] [Related]
2. Deregulation of HOX B13 expression in urinary bladder cancer progression.
Marra L; Cantile M; Scognamiglio G; Perdonà S; La Mantia E; Cerrone M; Gigantino V; Cillo C; Caraglia M; Pignata S; Facchini G; Botti G; Chieffi S; Chieffi P; Franco R
Curr Med Chem; 2013 Feb; 20(6):833-9. PubMed ID: 23276138
[TBL] [Abstract][Full Text] [Related]
3. Deregulation of paralogous 13 HOX genes in oral squamous cell carcinoma.
Aquino G; Franco R; Sabatino R; Mantia EL; Scognamiglio G; Collina F; Longo F; Ionna F; Losito NS; Liguori G; Botti G; Cantile M
Am J Cancer Res; 2015; 5(10):3042-55. PubMed ID: 26693058
[TBL] [Abstract][Full Text] [Related]
4. Paralogous HOX13 Genes in Human Cancers.
Botti G; Cillo C; De Cecio R; Malzone MG; Cantile M
Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31137568
[TBL] [Abstract][Full Text] [Related]
5. Altered expressions of HOX genes in human cutaneous malignant melanoma.
Maeda K; Hamada J; Takahashi Y; Tada M; Yamamoto Y; Sugihara T; Moriuchi T
Int J Cancer; 2005 Apr; 114(3):436-41. PubMed ID: 15551325
[TBL] [Abstract][Full Text] [Related]
6. Increased HOX C13 expression in metastatic melanoma progression.
Cantile M; Scognamiglio G; Anniciello A; Farina M; Gentilcore G; Santonastaso C; Fulciniti F; Cillo C; Franco R; Ascierto PA; Botti G
J Transl Med; 2012 May; 10():91. PubMed ID: 22583695
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation profiling of well-differentiated thyroid cancer uncovers markers of recurrence free survival.
Mancikova V; Buj R; Castelblanco E; Inglada-Pérez L; Diez A; de Cubas AA; Curras-Freixes M; Maravall FX; Mauricio D; Matias-Guiu X; Puig-Domingo M; Capel I; Bella MR; Lerma E; Castella E; Reverter JL; Peinado MÁ; Jorda M; Robledo M
Int J Cancer; 2014 Aug; 135(3):598-610. PubMed ID: 24382797
[TBL] [Abstract][Full Text] [Related]
8. HOXC10 up-regulation contributes to human thyroid cancer and indicates poor survival outcome.
Feng X; Li T; Liu Z; Shi Y; Peng Y
Mol Biosyst; 2015 Nov; 11(11):2946-54. PubMed ID: 26279264
[TBL] [Abstract][Full Text] [Related]
9. HOX D13 expression across 79 tumor tissue types.
Cantile M; Franco R; Tschan A; Baumhoer D; Zlobec I; Schiavo G; Forte I; Bihl M; Liguori G; Botti G; Tornillo L; Karamitopoulou-Diamantis E; Terracciano L; Cillo C
Int J Cancer; 2009 Oct; 125(7):1532-41. PubMed ID: 19488988
[TBL] [Abstract][Full Text] [Related]
10. Reduced expression of N-Myc downstream-regulated gene 2 in human thyroid cancer.
Zhao H; Zhang J; Lu J; He X; Chen C; Li X; Gong L; Bao G; Fu Q; Chen S; Lin W; Shi H; Ma J; Liu X; Ma Q; Yao L
BMC Cancer; 2008 Oct; 8():303. PubMed ID: 18940011
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.
Chevillard S; Ugolin N; Vielh P; Ory K; Levalois C; Elliott D; Clayman GL; El-Naggar AK
Clin Cancer Res; 2004 Oct; 10(19):6586-97. PubMed ID: 15475448
[TBL] [Abstract][Full Text] [Related]
12. ABCG2/BCRP gene expression is related to epithelial-mesenchymal transition inducer genes in a papillary thyroid carcinoma cell line (TPC-1).
Mato E; González C; Moral A; Pérez JI; Bell O; Lerma E; de Leiva A
J Mol Endocrinol; 2014 Jun; 52(3):289-300. PubMed ID: 24643400
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical detection of paralogous 13 HOX genes in phyllodes tumor of the breast as a useful diagnostic tool.
Sarno S; Cerrone M; Gigantino V; Scognamiglio G; Cantile M; Botti G; Di Bonito M
Int J Clin Exp Pathol; 2020; 13(9):2348-2351. PubMed ID: 33042341
[TBL] [Abstract][Full Text] [Related]
14. IGF-IEc Expression Is Associated With Advanced Differentiated Thyroid Cancer.
Karagiannis AK; Philippou A; Tseleni-Balafouta S; Zevolis E; Nakouti T; Tsopanomichalou-Gklotsou M; Psarras V; Koutsilieris M
Anticancer Res; 2019 Jun; 39(6):2811-2819. PubMed ID: 31177118
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA profile of poorly differentiated thyroid carcinomas: new diagnostic and prognostic insights.
Dettmer MS; Perren A; Moch H; Komminoth P; Nikiforov YE; Nikiforova MN
J Mol Endocrinol; 2014 Apr; 52(2):181-9. PubMed ID: 24443580
[TBL] [Abstract][Full Text] [Related]
16. Hox-D genes expression in pediatric low-grade gliomas: real-time-PCR study.
Buccoliero AM; Castiglione F; Rossi Degl'Innocenti D; Ammanati F; Giordano F; Sanzo M; Mussa F; Genitori L; Taddei GL
Cell Mol Neurobiol; 2009 Feb; 29(1):1-6. PubMed ID: 18404365
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of HOX genes in neoplastic and non-neoplastic human astrocytes.
Abdel-Fattah R; Xiao A; Bomgardner D; Pease CS; Lopes MB; Hussaini IM
J Pathol; 2006 May; 209(1):15-24. PubMed ID: 16463268
[TBL] [Abstract][Full Text] [Related]
18. Expression profiles of 39 HOX genes in normal human adult organs and anaplastic thyroid cancer cell lines by quantitative real-time RT-PCR system.
Takahashi Y; Hamada J; Murakawa K; Takada M; Tada M; Nogami I; Hayashi N; Nakamori S; Monden M; Miyamoto M; Katoh H; Moriuchi T
Exp Cell Res; 2004 Feb; 293(1):144-53. PubMed ID: 14729064
[TBL] [Abstract][Full Text] [Related]
19. Differential Hox expression in murine embryonic stem cell models of normal and malignant hematopoiesis.
Wheadon H; Ramsey JM; Dobbin E; Dickson GJ; Corrigan PM; Freeburn RW; Thompson A
Stem Cells Dev; 2011 Aug; 20(8):1465-76. PubMed ID: 21083428
[TBL] [Abstract][Full Text] [Related]
20. Expression of lumbosacral HOX genes, crucial in kidney organogenesis, is systematically deregulated in clear cell kidney cancers.
Cantile M; Schiavo G; Franco R; Cindolo L; Procino A; D'Armiento M; Facchini G; Terracciano L; Botti G; Cillo C
Anticancer Drugs; 2011 Jun; 22(5):392-401. PubMed ID: 21403516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
